2015 Pancreatic Diseases Gordon Research Conference

2015年胰腺疾病戈登研究会议

基本信息

  • 批准号:
    8970783
  • 负责人:
  • 金额:
    $ 1.5万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-06-19 至 2016-05-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): The distinctive concept of this GRC is to bring together basic and physician scientists at the forefront of research in all aspects of pancreatic diseases, including diabetes, pancreatic cancer and pancreatitis. These complex diseases represent a major threat for human health and society and advancement in their understanding and treatment requires an interdisciplinary approach. Given the close developmental and physiological relatedness of pancreatic exocrine and endocrine cells and the significant epidemiological association between pancreatic cancer and diabetes, it is especially felt that a forum for scientific exchange among leaders in these fields provides a unique opportunity to establish new collaborations and foster much needed progress in these research areas and translation of this information into medical practice. Accordingly, a specific objective of this GRC is the creation and consolidation through its biennial gathering of a cohesive research community including experts in medicine, biology, chemistry and pharmacology dedicated to the study of the pancreas and the cure of its related disorders. Following the success of the first conference, the second GRC "Pancreatic Diseases" will take place July 19- 24, 2015 at Mount Holyoke College South Hadley, MA, USA. The program that has been assembled is first- rate, benefitting from the contribution of international world-class scientists engaged in research relevant to different aspects of pancreatic diseases. The ultimate goal of the conference is the identification of novel concepts in pancreatic diseases that might be exploitable for pharmacological and cell-based therapeutic approaches. As for all GRCs, the guiding principle of this Conference is the presentation of new, unpublished results and the free, unhampered discussion that follows. Participation of young scientists, including PhD students, postdocs and junior group leaders is especially welcome, with opportunities of short talks and poster presentations.
 描述(由申请人提供): 这个GRC的独特概念是汇集基础和医生科学家在胰腺疾病的各个方面,包括糖尿病,胰腺癌和胰腺炎的研究前沿。这些复杂的疾病对人类健康和社会构成了重大威胁,要想进一步了解和治疗这些疾病,就需要采取跨学科的方法。鉴于胰腺外分泌和内分泌细胞的密切发育和生理相关性以及胰腺癌和糖尿病之间的重要流行病学关联,特别认为这些领域的领导者之间的科学交流论坛提供了一个独特的机会,以建立新的合作,并促进这些研究领域急需的进展,并将这些信息转化为医疗实践。因此,该GRC的一个具体目标是通过两年一次的聚会创建和巩固一个有凝聚力的研究社区,包括医学,生物学,化学和药理学专家,致力于胰腺的研究及其相关疾病的治疗。继第一次会议的成功,第二次GRC“胰腺疾病”将于2015年7月19日至24日在美国马萨诸塞州南哈德利的霍利奥克山学院举行。该计划已经组装是一流的,受益于国际世界级科学家的贡献,从事研究相关的胰腺疾病的不同方面。会议的最终目标是确定胰腺疾病的新概念,这些新概念可能可用于药理学和基于细胞的治疗方法。对于所有GRCs,本次会议的指导原则是介绍新的、未发表的结果,以及随后进行的自由、不受阻碍的讨论。特别欢迎年轻科学家,包括博士生,博士后和初级小组领导人的参与,并提供简短的演讲和海报展示的机会。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DIANE M SIMEONE其他文献

DIANE M SIMEONE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DIANE M SIMEONE', 18)}}的其他基金

Biomarker Validation in Pancreatic Cystic Neoplasms
胰腺囊性肿瘤的生物标志物验证
  • 批准号:
    10722347
  • 财政年份:
    2023
  • 资助金额:
    $ 1.5万
  • 项目类别:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
HR 缺陷型胰腺癌中的 POLQ 综合致死率
  • 批准号:
    10218126
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
HR 缺陷型胰腺癌中的 POLQ 综合致死率
  • 批准号:
    10442427
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
POLQ Synthetic Lethality in HR-Deficient Pancreatic Adenocarcinoma
HR 缺陷型胰腺癌中的 POLQ 综合致死率
  • 批准号:
    10656484
  • 财政年份:
    2020
  • 资助金额:
    $ 1.5万
  • 项目类别:
Oncogenic Function of ATDC in Bladder Cancer
ATDC 在膀胱癌中的致癌功能
  • 批准号:
    9491077
  • 财政年份:
    2014
  • 资助金额:
    $ 1.5万
  • 项目类别:
Oncogenic Function of ATDC in Bladder Cancer
ATDC 在膀胱癌中的致癌功能
  • 批准号:
    9017959
  • 财政年份:
    2014
  • 资助金额:
    $ 1.5万
  • 项目类别:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
项目3:lncRNA SNHG1和ATG7在基底亚型肌侵袭性膀胱肿瘤发生中的作用
  • 批准号:
    10661067
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
项目3:lncRNA SNHG1和ATG7在基底亚型肌侵袭性膀胱肿瘤发生中的作用
  • 批准号:
    10229414
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
Project 3: lncRNA SNHG1 and ATG7 in Basal-subtype Muscle-invasive Bladder Tumorigenesis
项目3:lncRNA SNHG1和ATG7在基底亚型肌侵袭性膀胱肿瘤发生中的作用
  • 批准号:
    10455731
  • 财政年份:
    2013
  • 资助金额:
    $ 1.5万
  • 项目类别:
P4 - ATDC as a Therapeutic Target in Pancreatic Cancer
P4 - ATDC 作为胰腺癌的治疗靶点
  • 批准号:
    7893337
  • 财政年份:
    2010
  • 资助金额:
    $ 1.5万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 1.5万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了